Журнал болезней крови и переливания крови

Абстрактный

Fibrinogen Maracaibo: Hypo-Dysfibrinogenemia Caused by a Heterozygous Mutation in the Gen that Encodes for the Fibrinogen Aα Chain (G.1194G>A: P.Gly13>Glu) with Diminished Thrombin Generation

Marchi R, Rojas H, Echenagucia M, Meyer M, Acosta M, Apitz R and Ruiz-Sáez A

Introduction: Hereditary fibrinogen abnormalities can be quantitative and/or qualitative. In hypofibrinogenemia and hypodysfibrinogenemia fibrinogen levels are below 150 mg/dL.

Objectives: The aim of the present work was to characterize the fibrinogen abnormalities in a family where the propositus (an asymptomatic four-year-old male) and his mother had prolonged thrombin time and low fibrinogen levels. Methods: Fibrinogen genes were sequenced. Preliminary studies were performed on fibrin (ogen) function and fibrin network characteristics. Fibrin formation kinetic was done in plasma and purified fibrinogen. Fibrin network porosity was measured and fibrin structure visualized by laser scanning confocal microscopy (LSCM). In addition, global haemostatic tests such as thrombin generation and thromboelastography were performed.

Results: DNA analysis revealed a heterozygous mutation in the fibrinogen gen that encoded for the Aα chain (FGA g.1194G>A: p.Gly13>Glu) in the propositus and his mother. In plasma and purified fibrinogen, the rate of patients´ fibrin formation was approximately two times slower compared to control. Propositus´ fibrin porosity was similar to control, but diminished in his mother (p<0.05). By LSCM patients’ clots morphology were similar to control. Thromboelastographic study was normal in both patients, and thrombin generation diminished in the propositus.

Conclusions: The mutation of fibrinogen at Aα Gly13>Glu impairs fibrin polymerization. The differences found in thrombin generation between the propositus and his mother highlights the utility of global assays for therapy individualization.